-+ 0.00%
-+ 0.00%
-+ 0.00%

COGNITION THERAPEUTICS ANNOUNCES ALIGNMENT WITH FDA ON PIVOTAL PHASE 3 TRIAL OF ZERVIMESINE (CT1812) IN DEMENTIA WITH LEWY BODIES

Reuters·10/22/2026 10:00:00

Please log in to view news